Condition: Asthma
Interventions: Drug: FLOVENT™ DISKUS™ 100 mcg BID; Drug: ADVAIR™ DISKUS™ 100/50 mcg BID
Sponsor: GlaxoSmithKline
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days